Intractable Crohn's colitis and perianal disease responding to cyclophosphamide and epirubicin

Nick Rieger, Jurgen Stahl, David Wattchow

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A case is reported where intractable Crohn's disease responded to chemotherapy for breast carcinoma. The drug most likely responsible was cyclophosphamide. Cyclophosphamide may have a role in the management of inflammatory bowel disease, but this needs to be confirmed before it can be recommended as a treatment option.

Original languageEnglish
Pages (from-to)2367-2369
Number of pages3
JournalDigestive Diseases and Sciences
Volume42
Issue number11
DOIs
Publication statusPublished - Nov 1997
Externally publishedYes

Keywords

  • Crohn's disease
  • Cyclophosphamide

Fingerprint Dive into the research topics of 'Intractable Crohn's colitis and perianal disease responding to cyclophosphamide and epirubicin'. Together they form a unique fingerprint.

  • Cite this